Company / Operating Income
ANAPTYSBIO, INC Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$47.9M
FY2025
5-year range
-$164.4M / $47.9M
FY2021-FY2025
Trend
+141.7%
vs FY2024
Sector context
#45 of 204
Health Care
What the data says
ANAPTYSBIO, INC's operating income of $48M is higher than 78% of companies in the Health Care sector (FY2025). Operating Income has fluctuated over the past 10 years, ranging from -$164M in FY2023 to $48M in FY2025.
Based on SEC 10-K filings.
$48M in FY2025. Top quartile in the Health Care sector.
Improved from -$164M to $48M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 204This company $47.9M Sector average $107.7M
▼
-55.5% below sector average
Key checks
Key Insights
- In FY2025, operating income increased 141.7% year-over-year.
- Ranks #45 out of 204 companies in the Health Care sector.
- Lowest operating income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $47.9M | +141.7% |
| FY2024 | -$114.9M | +30.1% |
| FY2023 | -$164.4M | -588.5% |
| FY2022 | -$23.9M | +77.8% |
| FY2021 | -$107.4M | -61.0% |
| FY2020 | -$66.7M | -131.8% |
| FY2019 | -$28.8M | +56.9% |
| FY2018 | -$66.7M | -1908.5% |
| FY2017 | -$3.3M | -9.8% |
| FY2016 | -$3.0M | +8.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026